|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash and due from banks | |||||||||||
| Fed funds sold | |||||||||||
| Cash and cash equivalents | |||||||||||
| Available for sale securities, stated at fair value | |||||||||||
| Loans held for sale | |||||||||||
| Loans, net of allowance for loan and lease losses of $2,264 and $2,118, respectively | |||||||||||
| Premises and equipment, net | |||||||||||
| Foreclosed assets | |||||||||||
| Other equity investments | |||||||||||
| Accrued interest receivable | |||||||||||
| Cash value of life insurance | |||||||||||
| Other assets | |||||||||||
| TOTAL ASSETS | |||||||||||
| Liabilities and Equity | |||||||||||
| Deposits | |||||||||||
| Advance payments by borrowers for taxes and insurance | |||||||||||
| FHLB advances | |||||||||||
| Accrued interest payable | |||||||||||
| Other liabilities | |||||||||||
| Total liabilities | |||||||||||
| Common stock ($0.01 par value, 19,000,000 shares authorized, 6,706,742 and 6,696,742 shares issued, 6,566,478 and 6,696,742 shares outstanding as of December 31, 2019 and 2018, respectively) | |||||||||||
| Additional paid in capital | |||||||||||
| Unallocated common stock of Employee Stock Ownership Plan ("ESOP") (230,343 and 243,303 shares at December 31, 2019 and 2018, respectively) | |||||||||||
| Retained earnings | |||||||||||
| Accumulated other comprehensive income (loss), net of income taxes | |||||||||||
| Less treasury stock, 140,264 and 0 shares at cost, at December 31, 2019 and 2018, respectively | |||||||||||
| Total equity | |||||||||||
| TOTAL LIABILITIES AND EQUITY |
Loading...
